Latest Airware Labs Corp. (AIRW) Headlines
AirWare
Latest Airware Labs Corp. (AIRW) Headlines
AirWare Labs Announces Additions to Executive Management Team
Marketwire - Wed Feb 19, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced additions to its executive management team:
AirWare Labs enters agreement with Breathe Active for national television media campaign
M2 - Wed Feb 12, 7:58AM CST
US-based health consumer company AirWare Labs Corp (OTCQB:AIRW) said on Tuesday that it has entered into a licensing agreement for AIR ALLERGY, AIR ESSENTIALS SLEEP/SNORE and AIR ESSENTIALS HEADACHE medical devices.
AirWare Labs Enters Licensing Agreement With Breathe Active, LLC
Marketwire - Tue Feb 11, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced a licensing agreement with Breathe Active, LLC for its AIR(TM) ALLERGY, AIR ESSENTIALS(TM) SLEEP/SNORE and AIR ESSENTIALS(TM) HEADACHE medical devices. Under the terms of the agreement, Breathe Active will offer these products to the public through a $2 million national television media campaign powered by Harvest Direct, a leading authority in direct response marketing and retail distribution.
AIR ALLERGY(TM) by AirWare Labs Selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference
Marketwire - Mon Jan 27, 7:10AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced that its AIR ALLERGY(TM) Advanced Nasal Filter has been selected as a 2014 Visionary Award Finalist for the VISION(R) Consumer Products Conference in Dallas, January 27-30, 2014.
AirWare Labs With Patented AIR(R) Products Shares Market Outlook
Marketwire - Tue Feb 19, 8:30AM CST
AirWare Labs Corp. (OTCQB: AIRW) today shares the market outlook for its AIR(R) product lineup in context to products sold within the OTC (Over-the-Counter) and Natural/Homeopathic Marketplaces.
AirWare Labs Announces Its Patented AIR(R) Products for Defense Against Flu & Allergy
Marketwire - Tue Jan 29, 8:30AM CST
AirWare Labs Corp. (OTCQB: AIRW) today announced it will expand its sales and promotional marketing efforts of the AIR(R) Allergy product in addition to the Sleep/Snore product as part of its continued commitment to a national rollout at Walgreens 7500 stores.
Item 9 Labs Corp. (INLB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Top 5 Most Recently Viewed Articles
DCHFA Welcomes Dr. Moreiça Allana-Kim Ortega The District of Columbia Housing Finance Agency (DCHFA) has announced an exciting new direction by creating an Office of Strategic Planning and Performance, under the leadership of Dr. Moreiça Allana-Kim Ortega. This new office is aimed at enhancing the effectiveness of the agency by addressing the evolving needs of housing...
Continue Reading
Cboe Achieves Major Milestone in ETF Listings Cboe Global Markets, Inc. (Cboe: CBOE) has achieved a remarkable feat by surpassing 1,000 U.S.-listed exchange-traded funds (ETFs). This notable accomplishment underscores Cboe's position as a premier venue for innovative actively-managed ETFs. The exchange has welcomed an impressive number of 185 new U.S. ETFs this year,...
Continue Reading
Eat Happy Kitchen Expands Retail Presence Nationally In an exciting development for health-conscious shoppers, Eat Happy Kitchen has significantly expanded its reach across the U.S. Nearly 500 stores under the Kroger family umbrella will now feature the woman-owned brand's all-natural line of pasta sauces. This rapid expansion is a testament to the growing demand for...
Continue Reading
Understanding ThreeD Capital's Recent NAV Announcement ThreeD Capital Inc. is a venture capital firm that carefully evaluates its financial standing to provide clarity to its stakeholders. Recently, the company disclosed that its unaudited net asset value (NAV) per share was valued at $0.76 as of December 31, 2024. This announcement reflects ThreeD’s commitment to...
Continue Reading
Simon Quick Advisors Introduces WealthMetrx™ for Tax Efficiency Simon Quick Advisors, a leading independent wealth management firm, has unveiled a new service called WealthMetrx™. This innovative approach aims to offer clients a comprehensive understanding of their tax profile by transforming intricate data into practical insights. With WealthMetrx™, clients can...
Continue Reading